COMPANY VALUATION IN EMERGING MARKETS

E-ISSN： 2051-3631|12|2|750-759

ISSN： 1741-6264

Source： International Journal of Management Cases, Vol.12, Iss.2, 2010-01, pp. : 750-759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Priority setting for health in emerging markets

By Glassman Amanda Giedion Ursula McQueston Kate

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 3, 2013-05 ,pp. : 283-291

Future Medicine

Access to resources Recommend Favorite

Considerations for clinical pharmacology studies for biologics in emerging markets

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. S3, 2015-03 ,pp. : S116-S122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors influencing scope and acceptability of E-detailing as a pharmaceutical marketing communication tool in emerging economies like India: Views of the company personnel

By Banerjee Saikat Dash Sampada Kumar

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 2, 2011-06 ,pp. : 153-168

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Company Profiles

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S2, 2015-07 ,pp. : 43-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

On the valuation of genetic tests

By Fossella John A

Personalized Medicine, Vol. 1, Iss. 1, 2004-12 ,pp. : 125-126

Future Medicine

Access to resources Recommend Favorite